162 related articles for article (PubMed ID: 11458940)
1. Chagas' disease.
Montero A; Giovannoni AG
Lancet; 2001 Jul; 358(9275):74. PubMed ID: 11458940
[No Abstract] [Full Text] [Related]
2. Antitrypanosomal agents: treatment or threat?
Issa VS; Bocchi EA
Lancet; 2010 Sep; 376(9743):768; author reply 768-9. PubMed ID: 20816538
[No Abstract] [Full Text] [Related]
3. [Allopurinol in the treatment of chronic Chagas' disease].
Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
[No Abstract] [Full Text] [Related]
4. Should benznidazole be used in chronic Chagas' disease?
Bestetti RB
Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
[No Abstract] [Full Text] [Related]
5. Antitrypanosomal therapy for chronic Chagas' disease.
Bern C
N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649
[No Abstract] [Full Text] [Related]
6. [Treatment of Chagas disease with benznidazole and thioctic acid].
Roldán EJ
Medicina (B Aires); 2005; 65(1):85-6; author reply 86-7. PubMed ID: 15830800
[No Abstract] [Full Text] [Related]
7. Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.
Alvarez MG; Vigliano C; Lococo B; Petti M; Bertocchi G; Viotti R
Trans R Soc Trop Med Hyg; 2012 Oct; 106(10):636-8. PubMed ID: 22898619
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of chronic Chagas' disease. Is the etiological treatment effective?].
Rassi A; Rassi Júnior A
Arq Bras Cardiol; 1998 Oct; 71(4):643-6. PubMed ID: 10347944
[No Abstract] [Full Text] [Related]
9. Severe drug-induced liver injury (DILI) associated with benznidazole therapy for Chagas' disease.
Giancola ML; Corpolongo A; Comandini UV; Del Nonno F; Montalbano M; Petrone A; Carrara S; Mariano A; Beccacece A; Maffongelli G; Nicastri E
J Antimicrob Chemother; 2022 Nov; 77(12):3515-3517. PubMed ID: 36173378
[No Abstract] [Full Text] [Related]
10. Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs.
Laguens RP; Cabeza Meckert P; Chambó JG; Gelpi R
Medicina (B Aires); 1983; 43(2):126-30. PubMed ID: 6420640
[No Abstract] [Full Text] [Related]
11. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].
Moya PR; Trombotto GT
Medicina (B Aires); 1988; 48(5):487-91. PubMed ID: 3151216
[No Abstract] [Full Text] [Related]
12. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
[TBL] [Abstract][Full Text] [Related]
13. [Tolerance to benzonidazole during the etiological treatment of Chagas' disease].
de Arruda Júnior ER
Arq Bras Cardiol; 1987 Jun; 48(6):395-7. PubMed ID: 3128252
[No Abstract] [Full Text] [Related]
14. Potential new clinical therapies for Chagas disease.
Bustamante JM; Tarleton RL
Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
[TBL] [Abstract][Full Text] [Related]
15. Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.
Garcia-Bournissen F; Altcheh J; Giglio N; Mastrantonio G; Della Védova CO; Koren G
Paediatr Drugs; 2009; 11(1):33-7. PubMed ID: 19127950
[TBL] [Abstract][Full Text] [Related]
16. Adverse events after the use of benznidazole in infants and children with Chagas disease.
Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H
Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000
[TBL] [Abstract][Full Text] [Related]
17. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
[TBL] [Abstract][Full Text] [Related]
18. Chronic Heart Disease after Treatment of Oral Acute Chagas Disease.
Antunes AF; Maduro SG; Pereira BV; Barbosa Md; Guerra JA; Ferreira JM
Arq Bras Cardiol; 2016 Aug; 107(2):184-6. PubMed ID: 27627643
[TBL] [Abstract][Full Text] [Related]
19. What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment.
Aldasoro E; Posada E; Requena-Méndez A; Calvo-Cano A; Serret N; Casellas A; Sanz S; Soy D; Pinazo MJ; Gascon J
J Antimicrob Chemother; 2018 Apr; 73(4):1060-1067. PubMed ID: 29351667
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]